10, 2024 — A scientific team has created a preclinical blood test to identify adults most likely to develop severe respiratory conditions, including chronic obstructive pulmonary disease (COPD).
Four survived with chronic pulmonary disease. One of those who survived is still symptomatic, with diffuse, faint rales bilaterally, mild subcostal retraction and slight cyanosis when crying.
Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) ...